Our Mission

To play a vital role in eliminating ‘best-guess’ antibiotic prescribing through our rapid and accurate antibiotic susceptibility tests, vastly reducing deaths.

10 million...

150 million...

Estimated deaths from antimicrobial resistance (AMR) by 2050

150 million...

Urinary tract infections (UTIs) recorded globally each year

1 in 4...

150 million...

1 in 4...

Sepsis cases linked to an earlier, poorly-treated, UTI

Discover More

'Personalising Antibiotic Prescribing' The Microplate Dx diagnostic platform enables rapid assessment of antibiotic susceptibility at the bedside, enabling the optimum (narrow-spectrum) antibiotic to be prescribed by a clinician in minutes rather than days.

Technology Details

From The Newsroom

Microplate Dx wins runner-up in Converge Challenge 2021

Find out more

Microplate Dx wins national pitching award

Microplate Dx wins runner-up in Converge Challenge 2021

Find out more

Get in Touch

Find us at:

Microplate Dx Limited

Wolfson Centre

106 Rottenrow

Glasgow

G4 0NW

United Kingdom

Send Message

Company Name

Contact Name (First, Last)*

Email*

Phone*

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Privacy Notice

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Decline Accept